Current literature has focused on lymphoblastoid cell lines (LCL’s), with a recent metabolic analysis performed on LCL’s obtained from patients with sporadic ALS, in addition to patients with familial mutations in FUS, SOD1 and TDP-43 [101]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.